BriaCell Therapeutics Corp. (BCTX)

BriaCell Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is August - July.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 31, 2025	Jul 31, 2025	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022	Jul 31, 2021
Cash & Equivalents	2.71	10.49	0.86	21.25	41.04	57.27
Short-Term Investments	7.46	7.37	-	-	-	-
Cash & Short-Term Investments	10.18	17.87	0.86	21.25	41.04	57.27
Cash Growth	75.68%	1972.44%	-95.94%	-48.22%	-28.34%	269412.38%
Other Receivables	1.17	-	0.74	-	0.02	0.01
Receivables	1.17	-	0.74	-	0.02	0.01
Prepaid Expenses	-	2.06	2.06	5.7	1.28	0.52
Total Current Assets	11.35	19.93	3.65	26.95	42.35	57.8
Property, Plant & Equipment	0.27	0.3	0.39	-	-	-
Long-Term Investments	0.55	0.52	0.42	0	0	0
Other Intangible Assets	0.18	0.18	0.2	0.22	0.23	0.25
Other Long-Term Assets	0.72	0.72	1.21	-	-	-
Total Assets	13.08	21.65	5.87	27.16	42.58	58.04
Accounts Payable	2.13	3.28	7.17	1.12	0.46	0.21
Accrued Expenses	1.19	0.69	0.29	0.68	0.48	0.34
Total Current Liabilities	3.32	3.98	7.46	1.8	0.94	0.56
Long-Term Debt	-	-	-	-	-	0.03
Other Long-Term Liabilities	0.41	0.34	1.1	29.14	31.31	29.79
Total Liabilities	3.72	4.32	8.56	30.94	32.25	30.37
Common Stock	101.74	101.74	72.17	69.59	65.59	54.77
Additional Paid-In Capital	-	-	-	-	-	2.18
Retained Earnings	-119.95	-111.76	-85.44	-80.65	-60.35	-29.14
Comprehensive Income & Other	28.19	27.9	10.89	7.28	5.09	-0.14
Total Common Equity	9.98	17.88	-2.38	-3.78	10.33	27.67
Minority Interest	-0.63	-0.55	-0.3	-	-	-
Shareholders' Equity	9.35	17.33	-2.68	-3.78	10.33	27.67
Total Liabilities & Equity	13.08	21.65	5.87	27.16	42.58	58.04
Total Debt	-	-	-	-	-	0.03
Net Cash (Debt)	10.18	17.87	0.86	21.25	41.04	57.24
Net Cash Growth	75.68%	1972.44%	-95.94%	-48.22%	-28.30%	-
Net Cash Per Share	11.98	42.23	7.86	204.08	397.33	1899.79
Filing Date Shares Outstanding	1.88	1.88	0.12	0.11	0.1	0.1
Total Common Shares Outstanding	1.88	1.88	0.12	0.11	0.1	0.1
Working Capital	8.03	15.95	-3.81	25.15	41.41	57.24
Book Value Per Share	5.30	9.49	-19.54	-35.45	99.84	271.83
Tangible Book Value	9.8	17.7	-2.58	-3.99	10.1	27.43
Tangible Book Value Per Share	5.20	9.39	-21.18	-37.47	97.61	269.42
Machinery	-	0.46	0.46	-	-	-

Updated Oct 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q